Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients.
作者信息
Ho Gwendolyn, Dusendang Jennifer R, Schmittdiel Julie, Kavecansky Juraj, Tavakoli Jahan, Pai Ashok
机构信息
Department of Hematology Oncology, The Permanente Medical Group, Kaiser Permanente, Sacramento, CA, USA.
Division of Research, Kaiser Permanente, Oakland, CA, USA.
出版信息
J Thromb Thrombolysis. 2021 Aug;52(2):476-481. doi: 10.1007/s11239-021-02383-w. Epub 2021 Feb 1.
Abstract
摘要
相似文献
1
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients.慢性抗凝和抗血小板药物使用与新型冠状病毒肺炎（SARS-CoV-2）感染患者疾病严重程度的关联。
J Thromb Thrombolysis. 2021 Aug;52(2):476-481. doi: 10.1007/s11239-021-02383-w. Epub 2021 Feb 1.
2
Highlights in COVID-19 from the 62nd American Society of Hematology Annual Meeting.第62届美国血液学会年会中关于新型冠状病毒肺炎的亮点
Clin Adv Hematol Oncol. 2021 Mar;19(3):140-143.
3
Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients.COVID-19 患者的死亡率、重症监护病房住院率和肺外并发症的预测因素。
Infect Dis Now. 2021 Sep;51(6):518-525. doi: 10.1016/j.idnow.2021.07.002. Epub 2021 Jul 7.
4
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California.加利福尼亚北部综合医疗系统中成年人 SARS-CoV-2 感染检测后 30 天静脉血栓栓塞发生率。
JAMA Intern Med. 2021 Jul 1;181(7):997-1000. doi: 10.1001/jamainternmed.2021.0488.
5
Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.英国两个重症监护病房中因严重新冠肺炎住院后90天随访的医院相关静脉血栓栓塞最新结果。
Thromb Res. 2020 Dec;196:454-456. doi: 10.1016/j.thromres.2020.10.007. Epub 2020 Oct 8.
6
Assessment of the Performance Consistency of an Adverse Outcome Prediction Tool for Patients Hospitalized With COVID-19.评估 COVID-19 住院患者不良结局预测工具的性能一致性。
JAMA Netw Open. 2021 Jul 1;4(7):e2118413. doi: 10.1001/jamanetworkopen.2021.18413.
7
Management of the antiplatelet therapy during the diagnosis of venous thromboembolism disease: A national survey of French general practitioners' compared to the French vascular physicians' management.静脉血栓栓塞性疾病诊断期间抗血小板治疗的管理：法国全科医生与血管科医生管理情况的全国性调查对比
J Med Vasc. 2020 May;45(3):107-113. doi: 10.1016/j.jdmv.2020.04.002. Epub 2020 Apr 22.
8
Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.他汀类药物治疗与深静脉血栓患者血栓溶解改善相关。
J Vasc Surg Venous Lymphat Disord. 2019 Mar;7(2):169-175.e4. doi: 10.1016/j.jvsv.2018.10.020. Epub 2019 Jan 16.
9
Spontaneous intracerebral hemorrhage with antiplatelets/anticoagulants/none: a comparison analysis.使用抗血小板药物/抗凝药物/未使用药物的自发性脑出血：一项对比分析
Acta Neurochir (Wien). 2014 Jul;156(7):1319-25. doi: 10.1007/s00701-014-2080-2. Epub 2014 Apr 27.
10
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19.COVID-19 住院患者中不同剂量低分子肝素的临床结局。
J Thromb Thrombolysis. 2021 Oct;52(3):782-790. doi: 10.1007/s11239-021-02401-x. Epub 2021 Mar 1.
引用本文的文献
1
Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis.新冠病毒病诊断前使用抗凝剂能否预防新冠病毒病相关急性静脉血栓栓塞：一项系统评价与荟萃分析
World J Methodol. 2024 Sep 20;14(3):92983. doi: 10.5662/wjm.v14.i3.92983.
2
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis.阿司匹林或其他抗血小板药物的使用与新冠肺炎患者全因死亡率之间的关联：一项荟萃分析。
Front Pharmacol. 2022 Oct 5;13:989903. doi: 10.3389/fphar.2022.989903. eCollection 2022.
3
Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials.2019冠状病毒病患者的抗血小板治疗：观察性研究和随机对照试验的系统评价与荟萃分析
Front Med (Lausanne). 2022 Sep 7;9:965790. doi: 10.3389/fmed.2022.965790. eCollection 2022.
4
Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study.口服抗凝剂与 COVID-19 相关结局的关联：一项基于人群的队列研究。
Br J Gen Pract. 2022 Jun 30;72(720):e456-e463. doi: 10.3399/BJGP.2021.0689. Print 2022 Jul.
5
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
6
[Rehabilitation and COVID disease: characterization and follow-up of hospitalized patients in Granada, Spain].[康复与新冠疾病：西班牙格拉纳达住院患者的特征及随访]
Rehabilitacion (Madr). 2022 Oct-Dec;56(4):328-336. doi: 10.1016/j.rh.2021.09.001. Epub 2021 Oct 7.
7
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.直接口服抗凝剂在 COVID-19 诊断前的使用与 30 天临床结局的关系。
Thromb Res. 2021 Sep;205:1-7. doi: 10.1016/j.thromres.2021.06.014. Epub 2021 Jun 27.
8
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis.抗血小板药物的使用与新冠肺炎患者的死亡风险：一项荟萃分析。
J Thromb Thrombolysis. 2021 Jul;52(1):124-129. doi: 10.1007/s11239-021-02436-0. Epub 2021 Apr 4.
本文引用的文献
1
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.COVID-19 住院前接受口服抗凝治疗患者的临床特征和预后。
Eur J Clin Invest. 2021 Jan;51(1):e13436. doi: 10.1111/eci.13436. Epub 2020 Nov 7.
2
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.与美国 2019 年冠状病毒病危重症患者死亡相关的因素。
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447. doi: 10.1001/jamainternmed.2020.3596.
3
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中，与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
4
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.新冠病毒感染前抗凝治疗的影响：一项倾向评分匹配队列研究。
Blood. 2020 Jul 2;136(1):144-147. doi: 10.1182/blood.2020006941.
5
Hospitalization and Mortality among Black Patients and White Patients with Covid-19.新冠病毒感染住院患者的病死率：黑人和白人患者的比较。
N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.
6
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.COVID-19 大流行期间的血栓栓塞和抗凝治疗：抗凝论坛的临时临床指南。
J Thromb Thrombolysis. 2020 Jul;50(1):72-81. doi: 10.1007/s11239-020-02138-z.
7
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
8
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
9
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
10
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment.国际血栓与止血学会（ISTH）关于新型冠状病毒肺炎（COVID-19）凝血功能障碍识别与管理的临时指南：一则评论
J Thromb Haemost. 2020 Aug;18(8):2060-2063. doi: 10.1111/jth.14860. Epub 2020 Jun 14.
Zotero 插件